Active gains on laquinimod data in RRMS

Active Biotech AB (SSE:ACTI) jumped SEK42.25 (33%) to SEK171 on Thursday after it and partner Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) said once-daily oral laquinimod met the primary endpoint...